ArticleScientific reports2026
A transparent osmotic wound dressing ATKPAD promotes the healing process and regulates hypoxia-dependent inflammatory responses.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The inflammatory response after skin injury initiates wound healing by promoting the release of cytokines and growth factors essential for tissue repair. Modern wound dressings promote healing by maintaining a moist, hypoxic environment. ATKPAD is a novel wound dressing that accelerates healing developed by Okamoto Industries, Inc. Composed of reduced starch syrup and a semi-permeable membrane, it was launched in Japan as a Class III medical device in 2024. Transparent ATKPAD allows wound visibility and absorbs exudate in a molecular-weight-dependent manner, with its semi-permeable membrane retaining larger molecules, like cytokines, while letting small molecules pass through osmotic effects rather than specific binding. However, the detailed molecular and cellular mechanisms of ATKPAD remain unclear. In this study, we examined its effect on full-thickness excisional wound healing. We analyzed the in vitro permeability of cytokines and growth factors and evaluated granulation tissue formation, angiogenesis, neutrophil infiltration, and cytokine and growth factor production in vivo. We observed an increase in cytokines and growth factors alongside accelerated wound healing with ATKPAD. Its application enhanced granulation tissue formation and neutrophil infiltration, accompanied by increased expression of Hif1α. These findings suggest that ATKPAD promotes wound healing by creating a hypoxic microenvironment that enhances early-phase inflammation. (Word count: 200).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.